Biotika AS (XBRA:1BSL01AE) 3-Year EBITDA Growth Rate : -48.10% (As of Jun. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Biotika AS 3-Year EBITDA Growth Rate?

Biotika AS's EBITDA per Share for the six months ended in Jun. 2023 was €1.86.

During the past 12 months, Biotika AS's average EBITDA Per Share Growth Rate was 30.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -48.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -31.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -15.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Biotika AS was 10.90% per year. The lowest was -48.10% per year. And the median was -7.60% per year.

Competitive Comparison of Biotika AS's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Biotika AS's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotika AS's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biotika AS's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Biotika AS's 3-Year EBITDA Growth Rate falls into.

Biotika AS 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Biotika AS (XBRA:1BSL01AE) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Biotika AS 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Biotika AS's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotika AS (XBRA:1BSL01AE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biotika AS (XBRA:1BSL01AE) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Slovenskc Lupca 566, Banská Bystrica, SVK, 976 13

Website

https://www.biotika.sk

Biotika AS is a manufacturer of pharmaceutical preparations for the human and veterinary application. It is engaged in the production of Active Pharmaceutical Ingredients (API), contract manufacturing of API, and contract manufacturing of final dosage formulations. It also offers research and development services. It manufacturers Polymyxine B Sulfate and other API for third parties (toll manufacturing) of pharmaceutical quality. Biotika is well known as a reliable manufacturer of high-quality pharmaceutical preparations for the human as well as veterinary application and also as a very important producer of the feed additives for breeding farm animals.

Biotika AS (XBRA:1BSL01AE) Headlines

No Headlines